Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
03/19/2009 | WO2008101448A4 Method of manufacturing 1-(2-deoxy-alpha-d-erythro-pentofuranosyl)-5-azacytosine |
03/19/2009 | US20090076295 Photocleavable protecting groups |
03/19/2009 | US20090076256 Degradation-resistant mononucleoside phosphate compounds |
03/19/2009 | US20090075931 isotope exchanged capecitabine, used for the treatment of metastatic breast cancer; anticarcinogenic agents |
03/19/2009 | US20090075930 for treating leukemia |
03/19/2009 | US20090075920 Deuterium-enriched decitabine |
03/19/2009 | US20090075342 Metabolic profile directed aptamer medicinal chemistry |
03/19/2009 | US20090075253 Bioreactive agents |
03/19/2009 | US20090071876 Desulfurizing agent manufacturing method and hydrocarbon desulfurization method |
03/18/2009 | EP2036897A1 Stable rhodamine labeling reagent |
03/18/2009 | EP2034834A2 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-BETA -D-RIBOFURANOSYL)-THIAZOLO[4,5-d]PYRIMIDIN-2,7-DIONE |
03/18/2009 | EP1994042A4 Preparation of gemcitabine |
03/18/2009 | CN101385738A Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
03/18/2009 | CN100469785C Method of reclaiming adenosine from low concentration Chinese caterpillar fungus fermentation waste water by large aperture adsorption resin |
03/17/2009 | US7504499 Methods of attaching biological compounds to solid supports using triazine |
03/17/2009 | US7504497 Thrombosis; anticoagulants; renal dialysis; bioavailability |
03/17/2009 | US7504496 Water-soluble rhodamine dye conjugates |
03/17/2009 | US7504495 Quencher compositions comprising anthraquinone moieties |
03/17/2009 | US7504489 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR) |
03/17/2009 | US7504215 Ligation; hybridization; photolithography; microRNA; microarrays |
03/17/2009 | CA2380205C Novel bicyclonucleoside analogues |
03/17/2009 | CA2355712C Antiviral nucleoside analogues |
03/17/2009 | CA2322231C Process for the purification of s-adenosyl-l-methionine and for the preparation of the pharmaceutically acceptable salts thereof |
03/12/2009 | WO2009030410A1 Improvements in or relating to compositions for the treatment or prophylaxis of viral infections |
03/12/2009 | WO2009030075A1 PROCESS FOR PREPARING 2'-DEOXY-2',2'-DIFLUORO-β-CYTIDINE HYDROCHLORIDE |
03/12/2009 | WO2008157751A3 Substituted imidazoheterocycles |
03/12/2009 | US20090069557 Preparation of gemcitabine |
03/12/2009 | US20090069556 Metabolically stable puromycin analogs |
03/12/2009 | US20090069500 Label target and labeling reagents comprising rigid group backbones |
03/12/2009 | US20090069268 Novel phosphoramidate compounds and methods of use |
03/12/2009 | US20090069263 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof |
03/12/2009 | US20090068751 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes |
03/12/2009 | US20090068695 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
03/12/2009 | US20090068125 Treatment for mucositis |
03/11/2009 | EP2033647A1 Agent against psychosocial stresses |
03/11/2009 | EP1165564B1 Process for preparing inhibitors of nucleoside metabolism |
03/11/2009 | CN101384609A Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
03/11/2009 | CN101381388A dTDP-D-furan type fucose and preparation method and application |
03/11/2009 | CN101381387A Method for preparing 2'-deoxy-2',2'-difluoro-beta-cytidine hydrochlorate |
03/11/2009 | CN101381382A Method for producing deoxynucleotide acid or salt thereof |
03/10/2009 | US7501506 Pentopyranosyl nucleic acid does not non-covalently bond or hybridize to naturally occurring DNA or RNA; conjugated through a covalent linkage to the biotin molecule; diagnosis, gene therapy |
03/10/2009 | US7501504 Labeled-imidazole-Polyethylene glycol compounds; nonpurine- and nonpyrimidine-based nucleotides; nucleotide sequence detectors; polymerization in the presence of deoxynucleotidyl transferase |
03/10/2009 | US7501500 Inhibiting denaturation of nucleic acid duplexes |
03/05/2009 | WO2009029888A2 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
03/05/2009 | WO2009029868A1 Phosphoramidite nucleoside analogs |
03/05/2009 | WO2009029729A1 Amino tricyclic-nucleoside compounds, compositions, and methods of use |
03/05/2009 | WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same |
03/05/2009 | WO2009005382A3 Derivatives of nucleoside-5'-o-hypophosphates and their mono- and dithiohypophosphate analogues and the process for the manufacture thereof |
03/05/2009 | WO2008154401A3 Carbocyclic bicyclic nucleic acid analogs |
03/05/2009 | WO2008150729A3 N-substituted-aminomethylene bridged bicyclic nucleic acid analogs |
03/05/2009 | US20090062543 Uv excitable fluorescent energy transfer dyes |
03/05/2009 | US20090062521 Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid |
03/05/2009 | US20090062314 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
03/05/2009 | US20090062223 Amino tricyclic-nucleoside compounds, compositions, and methods of use |
03/05/2009 | US20090062145 Labelled nucleotides |
03/05/2009 | US20090061437 Nucleotide Analogs |
03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
03/05/2009 | US20090060836 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue |
03/05/2009 | CA2697837A1 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
03/04/2009 | CN101379073A Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
03/04/2009 | CN101379061A Inhibitors of E1 activating enzyme |
03/04/2009 | CN101378725A Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same |
03/04/2009 | CN101376667A Intermediate for synthesizing azidothimidine, preparation thereof and use in azidothimidine synthesis |
03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
03/03/2009 | US7498426 Immunostimulatory oligonucleotide multimers |
03/03/2009 | US7498425 Immunostimulatory oligonucleotide multimers |
03/03/2009 | US7498320 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
03/03/2009 | CA2237368C 5'-deoxy-cytidine derivatives |
02/26/2009 | WO2008157688A3 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap |
02/26/2009 | US20090054369 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs |
02/26/2009 | US20090054258 Nucleic Acid Labeling Methods |
02/25/2009 | EP2027139A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiazolo [4, 5-d]pyrimidin-2-one |
02/25/2009 | EP1490383B1 Methods and compositions for identifying and characterizing hepatitis c |
02/25/2009 | CN101374850A DNA chip for diagnosis of corneal dystrophy |
02/25/2009 | CN101374529A Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
02/24/2009 | US7495095 useful in obtaining an oligonucleic acid capable of recognizing a specific base and transferring a nitrosyl group in a sequence-specific manner; sequence specific mutagenesis |
02/24/2009 | US7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
02/19/2009 | WO2009023855A2 Tetrahydropyran nucleic acid analogs |
02/19/2009 | WO2009006478A3 6-disubstituted bicyclic nucleic acid analogs |
02/19/2009 | US20090048427 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
02/19/2009 | US20090048203 Substituted adenines and the uses thereof |
02/19/2009 | US20090048202 Selective inhibitors of translesion dna replication |
02/19/2009 | US20090048190 Antiviral activity and resolution of 2-hydroxymethyl-5(5-fluorocytosin-1-yl)-1,3-oxathiolane |
02/19/2009 | US20090048189 Tricyclic-nucleoside compounds for treating viral infections |
02/19/2009 | US20090047712 Chemically cleavable phosphoramidite linkers |
02/19/2009 | CA2696497A1 Tetrahydropyran nucleic acid analogs |
02/18/2009 | EP2024380A2 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
02/18/2009 | CN101370945A Methods for identifying multiple DNA alteration markers in a large background of wild-type DNA |
02/18/2009 | CN101367856A Methods and compositions for treating hepatitis c virus |
02/18/2009 | CN100462441C Method of preparing a guanosine-group compound and an intermediate thereof |
02/17/2009 | US7491818 Oncology diagnosis; gene overexpression/underexpression; tumor suppressor genes |
02/17/2009 | US7491807 A DNA sequence encoding a methyl CpG binding endonuclease protien of a size between about 60 and 75 kilodaltons containing an amino-terminal methyl CpG-binding domain, an internal segment rich in positively charged amino acids and a carboxy-terminal catalytic domain, having deoxyribonuclease activity |
02/17/2009 | US7491677 Composite sample on support; concentration gradients |
02/17/2009 | US7491495 Adhering nucleotide sequences to solid support; gene expression analysis |
02/12/2009 | US20090042820 Tubulin Binding Anti Cancer Agents And Prodrugs Thereof |
02/11/2009 | EP2021350A1 Phosphorylated a2a receptor agonists |
02/11/2009 | CN101365791A Method for replication of nucleic acid and novel artificial base pair |
02/11/2009 | CN101362787A Method for preparing telbivudine |
02/11/2009 | CN100460417C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase |
02/11/2009 | CN100460416C Method for preparing adenosine |